Tenecteplase (TNK) (0.25 mg/kg, to maximum of 25mg) Clinical Trials
2 recruitingDrug
Phase 32
Showing 1–2 of 2 trials
Recruiting
Phase 3
Tenecteplase Before Interhospital Transfer for EVT in Acute Anterior Circulation LVO at 4.5-24 Hours
Acute Ischemic StrokeLarge Vessel OcclusionTransportation of Patients
Xuanwu Hospital, Beijing572 enrolled2 locationsNCT07253181
Recruiting
Phase 3
Tenecteplase for Intravenous Stroke Thrombolysis in Recent DOAC Users
Acute Ischemic Stroke
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University912 enrolled1 locationNCT07092709